Loading company details...
Beta
Latest Form 4 (Aug 21, 2026): Jennifer Tousignant (Chief Legal Officer): Sale of 4,212 shares, $103.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Jennifer Tousignant, Chief Legal Officer | Sale | 4,212 | $103.2K |
| Aug 18, 2026 | Radhika Tripuraneni, Chief Medical Officer | Exercise/Conversion | 40,000 | $528.4K |
| Jul 2, 2026 | Christopher W. Cain | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Jeffrey Robert Ajer | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Jennifer K. Moses | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Sarah Gheuens | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Tomas Kiselak | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Arlene Morris | Grant/Award | 32,341 | n/a |
| May 13, 2026 | Fairmount Funds Management LLC | Purchase | 1,176,470 | $20.00M |
| Mar 5, 2026 | Jennifer Tousignant, Chief Legal Officer | Exercise/Conversion | 5,169 | n/a |